Varian Breakfast Symposium
Date: Friday 18th October
Time: 7am – 8am
Ethos™ Therapy redefines personalised cancer care
An Adaptive Intelligence™ Solution
Patrik Sibolt is a Medical Physics Expert at the Department of Oncology, Herlev & Gentofte Hospital, Denmark. With a MSc in Medical Physics from Lund University in 2011, he has since held positions as clinical Medical Physicist, in combination with research activities. In 2018 he received his PhD from the Technical University of Denmark focusing on management of time-dependent geometries in radiotherapy.
Radiation treatment used to mean delivering the radiation each day exactly as originally planned, regardless of patient changes over the course of therapy. If organs shifted or the target changed size or shape, creating a new plan was too resource-intensive and time-consuming to undertake. That was yesterday.
Ethos therapy transforms cancer care with Adaptive Intelligence. It is the long-awaited solution that puts each patient truly at the centre of care. For the first time, radiation oncologists have powerful yet simple tools to achieve their intention for each patient, each and every day. They can see changes in patient anatomy, adapt the treatment plan within minutes, and deliver it, all within a typical 15-minute treatment timeslot. Online adaptive therapy is no longer an elusive aspiration, too complex and time-consuming to be practical and too exclusive for most clinics and patients. True to the Ethos name, this revolutionary therapy is within reach now for every cancer patient in virtually every hospital and cancer centre.
Learn more about Ethos therapy from our early clinical partners at this symposium.
AstraZeneca IR Breakfast
Date: Saturday 19 October
Time: 7.00am – 8.00am
CT guided lung biopsies – how we do it now and what should we do in the future
A/Prof Lloyd Ridley
A/Prof Lloyd Ridley is a staff specialist radiologist at the Repatriation General Hospital Concord, and a member of the discipline of Medical Imaging at the University of Sydney. His interests include chest and abdominal radiology. He is the author or co-author of almost 200 peer reviewed articles.
A/Prof. Ridley has been performing percutaneous lung biopsies for more than 20 years. He leads a team that has recently performed meta-analyses on several aspects of lung biopsies. He has also been an invited speaker on the radiological aspects of lung biopsies.
Despite the long history of radiologists performing lung biopsies there is little consensus in the best method. The literature contains a wide range of techniques, associated with a wide range of complication rates. This session aims to engage both those with experience in the technique, as well as to provide education for those with more limited training.
Components of the session will include:
How the requirements for lung biopsy have been changed by the new therapies
Review of the published guidelines for biopsies
Discussion of modifications to technique – what are some of the options, do they work and are they being used?
How I do it
Discussion of future directions